March 26 (Reuters) - The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk NOVOb.CO's insulin injection, Awiqli, to improve blood sugar levels in adults living with type 2 diabetes, the company said on Thursday.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.